MedPath

Serotonergic modulation of population receptive fields

Recruiting
Conditions
There is no specific disease being investigated
Registration Number
NL-OMON54157
Lead Sponsor
Spinoza Centre for Neuroimaging
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

Healthy english-speaking volunteers between 21 and 55 years old;
Male or female;
At least one previous experience with a hallucinogenic substance, but not in
the 4 weeks prior to the beginning of the study.

Exclusion Criteria

Personal, or first-degree relative with, diagnose of psychiatric conditions
(schizophrenia, bipolar disorders).
History of neurological disorders (including stroke, convulsion, epilepsy) as
well as concussion with loss of consciousness.
Used psychotropic drugs or medications over a period of 1 week prior to each
test session.
Currently using substances interacting with the metabolism of psilocybin or the
serotonergic system (e.g. monoamine oxidase inhibitors, SSRIs).
Contraindications for 7T MRI (e.g. claustrophobia, osteosynthetic material,
pacemaker, artificial cardiac valves, pregnancy, tinnitus).
Significant previous adverse response to a psychotropic substance.
Significant previous adverse response to fMRI scanning.
Participant does not speak English.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath